PMC:7600245 / 86464-86649 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T389","span":{"begin":137,"end":145},"obj":"Body_part"}],"attributes":[{"id":"A389","pred":"fma_id","subj":"T389","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"The clinical outcome is likely to be further improved by the addition of immune-therapeutics and anticoagulants to address the issues of cytokine storm and coagulopathies, respectively."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T89289","span":{"begin":97,"end":111},"obj":"Chemical"}],"attributes":[{"id":"A75245","pred":"chebi_id","subj":"T89289","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"}],"text":"The clinical outcome is likely to be further improved by the addition of immune-therapeutics and anticoagulants to address the issues of cytokine storm and coagulopathies, respectively."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T102","span":{"begin":137,"end":151},"obj":"Phenotype"},{"id":"T103","span":{"begin":156,"end":170},"obj":"Phenotype"}],"attributes":[{"id":"A102","pred":"hp_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A103","pred":"hp_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":"The clinical outcome is likely to be further improved by the addition of immune-therapeutics and anticoagulants to address the issues of cytokine storm and coagulopathies, respectively."}

{"project":"LitCovid-sentences","denotations":[{"id":"T672","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The clinical outcome is likely to be further improved by the addition of immune-therapeutics and anticoagulants to address the issues of cytokine storm and coagulopathies, respectively."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2633","span":{"begin":156,"end":170},"obj":"Disease"}],"attributes":[{"id":"A2633","pred":"tao:has_database_id","subj":"2633","obj":"MESH:D001778"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The clinical outcome is likely to be further improved by the addition of immune-therapeutics and anticoagulants to address the issues of cytokine storm and coagulopathies, respectively."}